NCT01537640View on ClinicalTrials.gov

Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy
Interventions
BIOLOGICAL

SAR231893 (REGN668) DP1

Pharmaceutical form:solution Route of administration: subcutaneous

BIOLOGICAL

SAR231893 (REGN668) DP2

Pharmaceutical form:solution Route of administration: subcutaneous

Trial Locations (1)

32117

Investigational Site Number 840001, Daytona Beach

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY

NCT01537640 - Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy Subjects | Biotech Hunter | Biotech Hunter